|
|
|
Insider
Information: |
Eastham Karin |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
195,379 |
|
Indirect Shares
|
1,000 |
|
|
Direct
Value |
$2,209,351 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
196,379 |
|
|
Total
Value |
$2,209,351 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Diversa Corp |
VRNM |
Sr. VP Finance, CFO & ... |
2004-04-29 |
6,419 |
2004-04-29 |
1,000 |
Premium* |
|
Sgx Pharmaceuticals, Inc. |
SGXP |
Director |
2008-08-20 |
0 |
|
0 |
Premium* |
|
Illumina Inc |
ILMN |
Director |
2019-05-23 |
10,049 |
2008-05-16 |
0 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2023-01-13 |
109,047 |
2009-05-29 |
0 |
Premium* |
|
Trius Therapeutics Inc |
TSRX |
Director |
2013-09-11 |
0 |
2013-09-11 |
0 |
Premium* |
|
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2012-08-08 |
0 |
2011-05-24 |
0 |
Premium* |
|
Veracyte, Inc. |
VCYT |
Director |
2024-04-01 |
33,125 |
2021-11-01 |
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Director |
2022-09-16 |
23,233 |
2018-09-27 |
0 |
Premium* |
|
Personalis, Inc. |
PSNL |
Director |
2022-05-17 |
13,506 |
2021-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ILMN |
Illumina Inc |
Director |
|
2011-03-17 |
4 |
OE |
$13.30 |
$96,900 |
D/D |
6,000 |
4,676 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2011-03-17 |
4 |
AS |
$62.80 |
$379,188 |
D/D |
(6,000) |
4,200 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2011-05-09 |
4 |
D |
$73.27 |
$52,754 |
D/D |
(720) |
3,480 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,440 |
4,920 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2011-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
69,000 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2011-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
74,000 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Director |
|
2011-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2011-06-01 |
4 |
OE |
$6.23 |
$62,250 |
D/D |
10,000 |
5,920 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2011-06-01 |
4 |
AS |
$72.39 |
$724,216 |
D/D |
(10,000) |
4,920 |
0 |
- |
|
TSRX |
Trius Therapeutics Inc |
Director |
|
2012-03-27 |
4 |
OE |
$3.50 |
$21,000 |
D/D |
6,000 |
18,114 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2012-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,440 |
6,360 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2012-06-01 |
4 |
OE |
$6.23 |
$90,550 |
D/D |
10,000 |
12,360 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2012-06-01 |
4 |
AS |
$41.72 |
$419,369 |
D/D |
(10,000) |
6,360 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Director |
|
2012-08-08 |
4 |
D |
$31.00 |
$186,000 |
D/D |
(6,000) |
0 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2012-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,500) |
71,500 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2013-04-18 |
4 |
D |
$56.33 |
$32,446 |
D/D |
(576) |
5,784 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2013-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
8,284 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2013-06-03 |
4 |
OE |
$13.30 |
$133,000 |
D/D |
10,000 |
18,284 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2013-06-03 |
4 |
AS |
$70.05 |
$703,398 |
D/D |
(10,000) |
8,284 |
0 |
- |
|
GERN |
Geron Corporation |
Director |
|
2013-07-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(45,000) |
26,500 |
0 |
- |
|
TSRX |
Trius Therapeutics Inc |
Director |
|
2013-09-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,000) |
0 |
0 |
- |
|
TSRX |
Trius Therapeutics Inc |
Director |
|
2013-09-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,114) |
0 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2013-11-01 |
4 |
AS |
$93.89 |
$949,925 |
D/D |
(10,000) |
8,284 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2013-11-01 |
4 |
OE |
$17.58 |
$175,750 |
D/D |
10,000 |
18,284 |
0 |
- |
|
VCYT |
Veracyte, Inc. |
Director |
|
2013-11-04 |
4 |
A |
$0.00 |
$0 |
I/I |
13,227 |
13,227 |
0 |
- |
|
122 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|